# Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study

> **NCT01820104** · PHASE1 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** lansoprazole, 30 mg per day for 6 days

## Key facts

- **NCT ID:** NCT01820104
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820104, "Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01820104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*